Annual Drug Patent Expirations for DUOBRII
Duobrii is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
Drug patent litigation for DUOBRII.
This drug has thirty-nine patent family members in twenty-one countries.
The generic ingredient in DUOBRII is halobetasol propionate; tazarotene. One supplier is listed for this compound. Additional details are available on the halobetasol propionate; tazarotene profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
